Evaluating oxidation processes in relation to cardiovascular disease: A current review of oxidant/antioxidant methodology

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 7, Issue 6, 1997, Pages 459-466

  Visioli, F ^a   Galli, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antioxidants; Atherosclerosis; Free radicals; Oxidants; Oxidative stress; Oxygen

Indexed keywords

EID: 0001533884     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity. N Engl J Med 320: 915-924
2. Steinberg D (1995) Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 346: 36-38
3. Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4: 2587-2597
4. Hertog MLG, Feskens EJM, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011
5. Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922
6. Garland D, Zigler JS, Kinoshit J (1986) Structural changes in bovine lens crystallins induced by ascorbate, metal, and oxygen. Arch Biochem Biophys 251: 771-776
7. Halliwell B (1995) Antioxidants: elixirs of life or tonics for tired sheep? The Biochemist 17: 3-6
8. Dormandy TL (1983) An approach to free radicals. Lancet II: 1010-1014
9. The alpha-tocopherol beta carotene cancer prevention study group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035
10. Jha JP, Flather M, Lonn E, Farkouh M, Yusuf S (1995) The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 123: 860-872
11. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344: 721-724
12. Halliwell B, Aeschbach R, Löliger J, Aruoma OI (1995) The characterization of antioxidants. Food Chem Toxicol 33: 601-617
13. Halliwell B, Gutteridge JMC (1990) The antioxidants of human extracellular fluids. Arch Biochem Biophys 280: 1-8
14. Aruoma OI (1994) Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32: 671-683
15. Lynch SM, Frei B (1993) Mechanisms of copper- and iron-dependent oxidative modification of human low-density lipoprotein. J Lipid Res 34: 1745-1753
16. Kaur H, Halliwell B (1994) Detection of hydroxyl radicals by aromatic hydroxylation. Meth Enzymol 233: 67-82
17. Kelly RA, Balligand JL, Smith TW (1996) Nitrix oxide and cardiac function. Circ Res 79: 363-380
18. Radi R, Cosgrove TP, Beckman JS, Freeman BA (1993) Peroxynitrite-induced luminol chemiluminescence. Biochem J 290: 51-57
19. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S (1993) The oxidation of alpha-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett 326: 199-203
20. 2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res 77: 335-341
21. Wieland E, Parthasarathy S, Steinberg D (1993) Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation? Proc Natl Acad Sci USA 90: 5929-5934
22. Visioli F, Bellomo G, Montedoro GF, Galli C (1995) Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 117: 25-32
23. Levin G, Modaky S (1994) Antioxidant activity of 9-cis compared to all-trans beta-carotene in vitro. Free Rad Biol Med 17: 77-82
24. Chen C, Loo G (1995) Effect of peroxyl radicals on lecithin/cholesterol acyltransferase activity in human plasma. Lipids 30: 627-631
25. Steinbrecher UP (1988) Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochim Biophys Acta 959: 20-25
26. Parthasarathy S, Wieland E, Steinberg D (1989) A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 86: 1046-1051
27. Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A (1987) Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 7: 55-61
28. Rankin SM, Parthasarathy S, Steinberg D (1991) Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res 32: 449-456
29. Frankel EN (1993) In search of better methods to evaluate natural antioxidants and oxidative stability in food lipids. Trends Food Sci Technol 4: 220-225
30. Auge N, Andrieu N, Negre-Salvayre A, Thiers JC, Levade T, Salvayre R (1996) The sphyngomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem 271: 19251-19255
31. Yarosh DB, Kripke ML (1996) DNA repair and cytokines in antimutagenesis and anticarcinogenesis. Mutat Res 350: 255-260
32. von Sonntag C, Schuchmann HP (1994) Pulse radiolysis. Methods Enzymol 233: 3-20
33. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercelloti GM (1991) Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11: 1700-1711
34. Pourplanche C, Larreta-Garde V, Thomas D (1991) Comparison of polarographic and chemical measurements of oxygen uptake in complex media: the example of lipoxygenase reaction. Anal Biochem 198: 160-164
35. Esterbauer H, Gebicki J, Puhl H, Jürgens G (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13: 341-390
36. Miyazawa T (1989) Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Chem 7: 209-217
37. North JA, Spector AA, Buettner GR (1992) Detection of lipid radicals by electron paramagnetic resonance spin trapping using intact cells enriched with polyunsaturated fatty acids. J Biol Chem 267: 5743-5746
38. Esterbauer H, Schaur RG, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondealdehyde and related aldehydes. Free Radic Biol Med 11: 81-128
39. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457
40. Hughes H, Mathews B, Lenz ML, Guyton JR (1994) Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholes-terol. Arterioscler Thromb 14: 1177-1185
41. 4-3-ketone derivatives. J Chromatogr A 691:247-254
42. Morrow JD, Harris TM, Jackson-Roberts L (1990) Non-cyclooxygenase oxidative formation of a series of novel prostaglandin: analytical ramification for measurement of eicosanoids. Anal Biochem 184: 1-10
43. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 93: 998-1004
44. 2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol. Pharmacol Res 31: 275-279
45. Stadtman ER, Oliver DN (1991) Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 266: 2005-2008
46. Brot N, Weissbach H (1991) Biochemistry of methionine sulfoxide residues in proteins. Biofactors 3: 91-96
47. Levine RL (1983) Oxidative modification of glutamine synthetase. J Biol Chem 258: 11823-11827
48. Amici A, Levine RL, Tsai L, Stadtman ER (1989) Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem 264: 3341-3346
49. Oliver CN (1987) Inactivation of enzymes and oxidative modification of proteins by stimulated neutrophils. Arch Biochem Biophys 253: 62-72
50. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375: 81-88
51. Ohshima H, Friesen M, Brouet I, Bartsch H (1990) Nitro-tyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol 28: 647-652
52. Hatch FT, Lees ES (1968) Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1-68
53. Spear N, Aust SD (1995) Hydroxylation of deoxyguanosine in DNA by copper and thiols. Arch Biochem Biophys 317: 142-148
54. Sies H, Menck CFM (1992) Singlet oxygen induced DNA damage. Mutat Res 275: 367-375
55. Hall DB, Holmlin RE, Barton JK (1996) Oxidative DNA damage through long-range electron transfer. Nature 382: 731-735
56. Halliwell B, Aruoma OI (1991) DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281: 9-19
57. Dizdaroglu M (1991) Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med 10: 225-242
58. Halliwell B, Aruoma OI. DNA and Free Radicals, Ellis Horwood, London, 1983.
59. Shigenaga MK, Gimeno CJ, Ames BN (1989) Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 86: 9697-9701
60. Fairbairn DW, Olive PL, O'Neill KL (1995) The comet assay: a comprehensive review. Mutat Res 339: 37-59
61. Halliwell B, Gutteridge JMC (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85
62. Lapenna D, Gioia SD, Mezzetti A, Ciofani G, Ilio CD, Cuccurullo F (1995) The prooxidant properties of captopril. Biochem Pharmacol 50: 27-32
63. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387
64. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89: 10721-10725
65. 2-isoprostanes) in smokers. N Engl J Med 332: 1198-1203
66. Loft S, Astrup A, Buemann B, Poulsne HE (1994) Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J 8: 534-537
67. Lunec J, Herbert K, Blount S, Griffiths HR, Emery P (1994) 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 348: 131-134
68. Tagesson C, Kallberg M, Klintenberg C, Starkhammar H (1995) Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. Eur J Cancer 31 A: 934-940
69. van Maanen JM, Moonen EJ, Maas LM, Kleinjans JC, van Schooten FJ (1994) Formation of aromatic DNA adducts in white blood cells in relation to urinary excretion of 1-hydroxypyrene during consumption of grilled meat. Carcinogenesis 15: 2263-2268
70. Tappel AL, Dillard CJ (1981) In vivo lipid peroxidation: measurement via exhaled penthane and protection by vitamin E. Fed Proc 40: 174-178
71. Hotz P, Hoet P, Lauwerys R, Buchet JP (1987) Development of a method to monitor low molecular mass hydrocarbons in exhaled breath of man: preliminary evaluation of its interest for detecting a lipoperoxidation process in vivo. Clin Chim Acta 162: 303-310
72. Whitehead TP, Thorpe GHG, Maxwell SRJ (1992) Enhanced chemiluminescence assay for antioxidant capacity in biological fluids. Anal Chim Acta 266: 265-277
73. Lissi E, Salim-Hanna M, Pascual C, Castillo MD (1995) Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18: 153-158
74. Visioli F, Galli C (1997) Evaluation of antioxidant capacity by chemiluminescence. Anal Biochem 249: 244-246
75. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A (1995) Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 41: 32-35
76. Rice-Evans C, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234: 279-293
77. Cao G, Alessio HM, Cutler RG (1993) Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 14: 303-311
78. Motchnik PA, Frei B, Ames BN (1994) Measurement of antioxidants in human blood plasma. Methods Enzymol 234: 269-279
79. Dabbagh AJ, Mannion T, Lynch SM, Frei B (1994) The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem J 300: 799-803
80. Mason RP, Knecht KT (1994) In vivo detection of radical adducts by electron spin resonance. Methods Enzymol 233: 112-117
81. Avogaro P, Bittolo-Bon G, Cazzolato G (1988) Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8: 79-87
82. Cazzolato G, Avogaro P, Bittolo-Bon G (1991) Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med 11: 247-253
83. Vedie B, Myara I, Pech MA, Maziere JC, Maziere C, Caprani A, Moatti N (1991) Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res 32: 1359-1369
84. Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A (1994) Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res 35: 669-677
85. Orekhov AN, Tertov VV, Kabakov AE, Adamova IY, Pokrovsky SN, Smirnov VN (1991) Autoantibodies against modified low density lipoprotein. Arterioscler Thromb 11: 316-326
86. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G (1994) LDL oxidation in patients with severe carotid atherosclerosis. Arterioscler Thromb 14: 1892-1899
87. Holvoet P, Perez G, Zhao Z, Brouvers E, Bernar H, Collen D (1995) Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest 95: 2611-2619
88. Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP (1993) Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein (a). Arterioscler Thromb 13: 1689-1699
89. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinsky W, Witzum JL (1992) Autoantibodies against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887
90. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G (1995) LDL oxidation in patients with carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thromb Vase Biol 14: 1892-1899
91. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J (1995) Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15: 441-445
92. Östling O, Johanson KJ (1984) Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123: 291-298
93. Collins AR, Duthie SJ, Dobson VL (1993) Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14: 1733-1735
94. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredsen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274-1277
95. Giulivi C, Davies KJA (1993) Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome. J Biol Chem 268: 8752-8759
96. Jessup W, Mohr D, Gieseg SP, Dean RT, Stocker R (1992) The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta 1180: 73-82
97. 2 mimics cell-mediated oxidative modification. J Lipid Res 29: 745-753